HK Stock MarketDetailed Quotes
01244 3D MEDICINES
Watchlist
8.850
+0.370+4.36%
Market Closed 11/30 16:08 CST
9.050High8.400Low2.13MVolume
8.600Open8.480Pre Close18.72MTurnover0.83%Turnover RatioLossP/E (TTM)2.29BMarket Cap131.50052wk HighLossP/E (Static)258.21MShares4.68052wk Low2.41P/B2.29BFloat Cap131.500Historical High--Dividend TTM258.21MShs Float4.680Historical Low--Dividend LFY7.67%Amplitude--Div YieldTTM8.781Avg Price500Lot Size--Div Yield LFY
3D MEDICINES Key Stats
All
YOY
| (Q6)2023/06/30 | (FY)2022/12/31 | (Q6)2022/06/30 | (FY)2021/12/31 | (FY)2020/12/31 | (FY)2019/12/31 | |
|---|---|---|---|---|---|---|
| Turnover | 70.29%352.55M | 841.57%567.39M | --207.03M | --60.26M | ---- | ---- |
| Operating income | 70.29%352.55M | 841.57%567.39M | 207.03M | 60.26M | ||
| Cost of sales | -79.56%-27.3M | -887.02%-42.22M | ---15.2M | ---4.28M | ---- | ---- |
| Operating expenses | -79.56%-27.3M | -887.02%-42.22M | -15.2M | -4.28M | ||
| Gross profit | 69.56%325.25M | 838.10%525.18M | 191.82M | 55.98M | ||
| Selling expenses | -62.78%-220.97M | -734.99%-357.66M | ---135.75M | ---42.83M | ---- | ---- |
| Administrative expenses | -55.28%-78.37M | 5.38%-142.83M | ---50.47M | -272.47%-150.96M | 1.37%-40.53M | ---41.09M |
| Research and development expenses | 12.43%-151.61M | 5.47%-350.86M | ---173.14M | -40.61%-371.16M | -15.07%-263.97M | ---229.39M |
| Revaluation surplus | ---- | 31.17%-657.16M | ---143.64M | -199.07%-954.74M | -23,830.43%-319.23M | ---1.33M |
| -Changes in the fair value of other assets | ---- | 31.17%-657.16M | ---143.64M | -199.07%-954.74M | -23,830.43%-319.23M | ---1.33M |
| Impairment and provision | -174.26%-277K | -803.85%-1.18M | ---101K | ---130K | ---- | ---- |
| -Other impairment is provision | -174.26%-277K | -803.85%-1.18M | ---101K | ---130K | ---- | ---- |
| Special items of operating profit | -430.86%-60.19M | -1,917.47%-64.41M | ---11.34M | 198.66%3.54M | 89.25%-3.59M | ---33.41M |
| Operating profit | 42.30%-186.16M | 28.17%-1.05B | -322.61M | -132.78%-1.46B | -105.53%-627.32M | -305.23M |
| Financing cost | -329.19%-4.04M | -103.73%-3.11M | ---942K | 81.04%-1.53M | 47.01%-8.06M | ---15.21M |
| Earning before tax | 41.21%-190.2M | 28.03%-1.05B | -323.55M | -130.07%-1.46B | -98.29%-635.38M | -320.43M |
| After-tax profit from continuing operations | 41.21%-190.2M | 28.03%-1.05B | -323.55M | -130.07%-1.46B | -98.29%-635.38M | -320.43M |
| Earning after tax | 41.21%-190.2M | 28.03%-1.05B | -323.55M | -130.07%-1.46B | -98.29%-635.38M | -320.43M |
| Minority profit | 22.39%-11.72M | 0.19%-27.68M | ---15.1M | ---27.73M | ---- | ---- |
| Profit attributable to shareholders | 42.14%-178.49M | 28.57%-1.02B | -308.45M | -125.71%-1.43B | -98.29%-635.38M | -320.43M |
| Basic earnings per share | 90.61%-0.79 | 38.67%-22.52 | -8.41 | -163.60%-36.72 | -34.20%-13.93 | -10.38 |
| Diluted earnings per share | 90.61%-0.79 | 38.67%-22.52 | -8.41 | -163.60%-36.72 | -34.20%-13.93 | -10.38 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--